通过抗微生物Api137和Api88的多模式结合和抑制细菌核糖体
Simon M Lauer1,2, Maren Reepmeyer3,4, Ole Berendes5
1Institute of Medical Physics and Biophysics, Charité - Berlin University of medicine, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.
Nature communications
|May 10, 2024
概括
像Api137和Api88这样的富含proline的抗微生物 (PrAMPs) 通过多个核糖体结合部位抑制细菌蛋白质合成. 这些新的机制为开发新的抗菌药物提供了有希望的途径.
科学领域:
- 微生物学 微生物学
- 生物化学 生化学
- 结构生物学 结构生物学
背景情况:
- 众所周知,富含的抗微生物 (PrAMPs) 抑制了细菌蛋白质生物合成.
- 它们主要准细菌核糖体的基转移酶中心附近的聚酸脱出道 (PET).
- 像Api137这样的apidaecin衍生是优化的PrAMP,可以捕获释放因子 (RF) 来抑制翻译.
研究的目的:
- 阐明Api137及其类似物Api88抑制细菌蛋白质合成的详细机制.
- 为了调查潜在的替代或额外的结合场所和作用模式,超越RF-trapping.
主要方法:
- 电子显微镜 (cryo-EM) 用于结构的确定.
- 功能性测试以评估翻译抑制.
- 分子动态 (MD) 模拟用于分析-核糖体相互作用.
主要成果:
- Api137与PET中的两个不同的位置结合,包括道出口附近的一个新网站,使RF独立的翻译抑制成为可能.
- Api88是一种C端胺类同类物,与Api137相同的部位和额外的第三口袋结合.
- Api88可能通过独立于RF捕获的机制抑制翻译.
结论:
- 虫素衍生PrAMPs采用多模式机制来抑制细菌核糖体.
- 在PrAMPs中,微小的结构修改导致了不同的结合模式和抑制功能.
- 这些代表了开发新型抗菌剂的有希望的类别.
相关概念视频
Antimicrobial Proteins
982
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
982
Types of RNA
63.6K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.6K
Riboswitches
8.1K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.1K
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Factors Affecting Protein-Drug Binding: Drug-Related Factors
98
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
98
Bacterial Signaling
32.0K
Bacterial signaling can occur within bacteria (intracellular) or between bacteria (intercellular). At times, a group of bacteria behaves like a community. To achieve this, they engage in quorum sensing, the perception of higher cell density that causes changes in gene expression. Quorum sensing involves both extracellular and intracellular signaling. The signaling cascade starts with a molecule called an autoinducer (AI). Individual bacteria produce AIs that move out of the bacterial cell...
32.0K


